Surgical Innovations Group PLC Directorate Change (2188X)
December 19 2023 - 1:00AM
UK Regulatory
TIDMSUN
RNS Number : 2188X
Surgical Innovations Group PLC
19 December 2023
Surgical Innovations Group Plc
("Surgical Innovations", the "Company" or the "Group")
Directorate Change
Surgical Innovations Group Plc (AIM: SUN), the designer,
manufacturer and distributor of innovative technology for minimally
invasive surgery, announces that Charmaine Day has notified the
Board of her intention to step down from her role as Chief
Financial Officer ('CFO') and Company Secretary in order to pursue
other opportunities.
The Company will begin an extensive search to find the correct
candidate for the CFO position and an orderly transition process
will take place, aided by Charmaine, ahead of her departure from
Surgical Innovations. Charmaine has committed to stay until the
transition to her successor is complete.
CEO, David Marsh, commented: "It has been a pleasure to work
with Charmaine since she joined Surgical Innovations in 2012, and
especially in the role of CFO since 2021, and I would like to thank
her for the excellent and continued contribution that she brings to
the business.
"We will begin the search imminently to find a new CFO and will
effect an orderly handover once the right candidate has been
selected, with both aspects of the transition supported by
Charmaine. We look forward to providing an update in due
course."
The Company's next scheduled trading update will be late January
2024
For further information please contact:
Surgical Innovations Group plc www sigroupplc com
David Marsh, CEO Tel: 0113 230 7597
Charmaine Day, CFO
Singer Capital Markets (Nominated Tel: 020 7496 3000
Adviser & Broker)
Aubrey Powell / Oliver Platts
Walbrook PR (Financial PR & Investor Tel: 020 7933 8780 or si@walbrookpr.com
Relations)
Paul McManus / Charlotte Edgar Mob: 07980 541 893 / 07584 391 303
/ Alice Woodings / 07407 804 654
About Surgical Innovations Group plc
The Group specialises in the design, manufacture, sale and
distribution of innovative, high quality medical products,
primarily for use in minimally invasive surgery. Our product and
business development is guided and supported by a key group of
nationally and internationally renowned surgeons across the
spectrum of minimally invasive surgical activity.
We design and manufacture and source our branded port access
systems, surgical instruments and retraction devices which are sold
directly in the UK home market through our subsidiary, Elemental
Healthcare, and exported widely through a global network of trusted
distribution partners. Many of our products in this field are based
on a "resposable" concept, in which the products are part reusable,
part disposable, offering a high quality and environmentally
responsible solution at a cost that is competitive against fully
disposable alternatives.
Elemental also has exclusive UK distribution for a select group
of specialist products employed in laparoscopy, bariatric and
metabolic surgery, hernia repair and breast reconstruction.
In addition, we design and develop medical devices for carefully
selected OEM partners and have also collaborated with a major UK
industrial partner to provide precision engineering solutions to
complex problems outside the medical arena.
We aim for our brands to be recognised and respected by
healthcare professionals in all major geographical markets in which
we operate and provide by development, partnership or acquisition a
broad portfolio of cost effective, procedure specific surgical
instruments and implantable devices that offer reliable solutions
to genuine clinical needs in the operating theatre environment.
Further information
Further details of the Group's businesses and products are
available on the following websites:
www.sigroupplc.com
www.surginno.com
www.elementalhealthcare.co.uk
To receive regular updates by email, please contact
si@walbrookpr.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAGPGMGPUPWPGR
(END) Dow Jones Newswires
December 19, 2023 02:00 ET (07:00 GMT)
Surgical Innovations (LSE:SUN)
Historical Stock Chart
From Dec 2024 to Jan 2025
Surgical Innovations (LSE:SUN)
Historical Stock Chart
From Jan 2024 to Jan 2025